The Food and Drug Administration today published a proposed rule that would update requirements under the Mammography Quality Standards Act of 1992, which authorized FDA oversight of mammography facilities. According to the agency, the rule would expand the information that mammography facilities must provide to patients and health care professionals, modernize mammography quality standards and enhance facility oversight. For example, the rule would require that the facility report information on breast density in the report to the clinician and the patient’s summary letter to enable patients and their doctors to have a more informed discussion about the enhanced risks associated with dense breasts if appropriate. The agency will accept comments on the proposed rule for 90 days.

Related News Articles

Perspective
In Michigan, African Americans make up 14% of the population … but account for 40% of the COVID-19 deaths. In Chicago: 30% of the population … and 46% of the…
Headline
The Department of Health and Human Services’ Office of Minority Health May 1 announced it will provide funding to help deliver important COVID-19-related…
Headline
Hospitals and health systems continue to provide care for our most vulnerable communities by addressing social needs, educating on COVID-19 risks and…
Headline
A study of 305 hospitalized adult COVID-19 patients in Georgia found an overrepresentation of black patients, with over a quarter lacking known risk factors,…
Blog
The AHA is committed to ensuring that all people, regardless of background or zip code, have equitable access to quality health care. As the COVID-19 pandemic…
Headline
The AHA’s Institute for Diversity and Health Equity today released a new resource highlighting steps hospitals can and are taking to address disparities that…